Update on the CAPTIVATE trial of ibrutinib plus venetoclax

Clin Adv Hematol Oncol. 2023 Dec;21(12):654-657.NO ABSTRACTPMID:38039059
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Authors: Source Type: research